Marketed By: AGP (Pvt) Ltd.
Therapeutic Segment: Sulphonylurea A-Diabetes/Anti-Diabetic
In combination with insulin to lower blood glucose in patients whose hyperglycemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycemic agent.
As an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin-dependent (Type 2) diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled by diet and exercise alone.
Pack Size: 20's